UK bladder cancer study weighs biomarker role
This article was originally published in Clinica
Executive Summary
The UK NHS is eyeing the possibility of replacing cytology and cystoscopy with biomarkers as the central diagnostics for bladder cancer. A health technology assessment of urine tests and photodynamic diagnostics (PDD) for the detection and follow-up of bladder cancer is part of a wider review due to be completed by the end of 2008.